SANTA MONICA, Calif. & SAN FRANCISCO--(BUSINESS WIRE)--Kite Pharma, Inc. (NASDAQ: KITE) (“Kite”) and Cell Design Labs, Inc. today announced a research collaboration and license agreement to develop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results